Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'melphalan' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 973 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ten Hagen, TLM; Seynhaeve, ALB; Van Tiel, ST; Ruiter, DJ; Eggermont, AMM
      Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil (R)) in soft tissue sarcoma-bearing rats

      INTERNATIONAL JOURNAL OF CANCER
    2. Fisher, MD
      Update of the French studies of autologous transplantation in multiple myeloma

      CLINICAL LYMPHOMA
    3. Ferroni, P; Di Filippo, F; Martini, F; Spila, A; D'Alessandro, R; Cavaliere, F; Anza, M; Garinei, R; Aloe, S; Carone, MD; Gazzaniga, PP; Guadagni, F
      Effects of isolated limb perfusion with tumor necrosis factor-alpha on circulating levels of proinflammatory cytokines

      JOURNAL OF IMMUNOTHERAPY
    4. ten Hagen, TLM; Eggermont, AMM; Lejeune, FL
      TNF is here to stay - revisited

      TRENDS IN IMMUNOLOGY
    5. Samson, D; Singer, CRJ
      Multiple myeloma

      CLINICAL MEDICINE
    6. Gulbrandsen, N; Wisloff, F; Brinch, L; Carlson, K; Dahl, IM; Gimsing, P; Hippe, E; Hjorth, M; Knudsen, LM; Lamvik, J; Lenhoff, S; Lofvenberg, E; Nesthus, I; Nielsen, JL; Turesson, L; Westin, J
      Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support

      MEDICAL ONCOLOGY
    7. Dubrey, SW; Burke, MM; Khaghani, A; Hawkins, PN; Yacoub, MH; Banner, NR
      Long term results of heart transplantation in patients with amyloid heart disease

      HEART
    8. Somlo, G; Chow, W; Hamasaki, V; Leong, L; Margolin, K; Morgan, R; Sniecinski, I; Frankel, P; Reardon, D; Longmate, J; Raschko, J; Shibata, S; O'Donnell, M; Smith, E; Tetef, M; Forman, S; Yen, Y; Molina, A; Doroshow, JH
      Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    9. Lans, TE; Bartlett, DL; Libutti, SK; Gnant, MFX; Liewehr, DJ; Venzon, DJ; Turner, EM; Alexander, HR
      Role of tumor necrosis factor on toxicity and cytokine production after isolated hepatic perfusion

      CLINICAL CANCER RESEARCH
    10. Anderson, CP; Seeger, RC; Satake, N; Monforte-Munoz, HL; Keshelava, N; Bailey, HH; Reynolds, CP
      Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    11. Mackall, CL; Helman, LJ
      High-dose chemotherapy for rhabdomyosarcoma: Where do we go from here

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    12. Weigel, BJ; Breitfeld, PP; Hawkins, D; Crist, WM; Baker, KS
      Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    13. Raney, RB; Anderson, JR; Barr, FG; Donaldson, SS; Pappo, AS; Qualman, SJ; Wiener, ES; Maurer, HM; Crist, WM
      Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: A selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for intergroup rhabdomyosarcoma study V

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    14. Breitfeld, PP; Lyden, E; Raney, RB; Teot, LA; Wharam, M; Lobe, T; Crist, WM; Maurer, HM; Donaldson, SS; Ruymann, FB
      Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: A report from the Intergroup Rhabdomyosarcoma Study Group

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    15. Daryanani, D; Komdeur, R; Ter Veen, J; Nijhuis, PH; Piers, DA; Hoekstra, HJ
      Continuous leakage measurement during hyperthermic isolated limb perfusion

      ANNALS OF SURGICAL ONCOLOGY
    16. Sakaeda, T; Tada, Y; Sugawara, T; Ryu, T; Hirose, F; Yoshikawa, T; Hirano, K; Kupczyk-Subotkowska, L; Siahaan, TJ; Audus, KL; Stella, VJ
      Conjugation with L-glutamate for in vivo brain drug delivery

      JOURNAL OF DRUG TARGETING
    17. Sharma, A; Mani, S; Hanna, N; Guha, C; Vikram, B; Weichselbaum, RR; Sparano, J; Sood, B; Lee, D; Lee, D; Regine, W; Muhodin, M; Valentino, J; Herman, J; Desimone, P; Arnold, S; Carrico, J; Rockich, AK; Warner-Carpenter, J; Barton-Baxter, M
      An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade (TM) biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors

      HUMAN GENE THERAPY
    18. Roberts, MS; Wu, ZY; Siebert, GA; Anissimov, YG; Thompson, JF; Smithers, BM
      Pharmacokinetics and pharmacodynamics of melphalan in isolated limb infusion for recurrent localized limb malignancy

      MELANOMA RESEARCH
    19. Liang, Y; Meleady, P; Cleary, I; McDonnell, S; Connolly, L; Clynes, M
      Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness

      EUROPEAN JOURNAL OF CANCER
    20. Orlandi, L; Colella, G; Bearzatto, A; Abolafio, G; Manzotti, C; Daidone, MG; Zaffaroni, N
      Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cellcycle progression and induction of apoptosis

      EUROPEAN JOURNAL OF CANCER
    21. Zaffaroni, N; De Marco, C; Villa, R; Riboldi, S; Daidone, MG; Double, JA
      Cell growth inhibition, G(2)M cell cycle arrest and apoptosis induced by the imidazoacridinone C1311 in human tumour cell lines

      EUROPEAN JOURNAL OF CANCER
    22. Egerer, G; Hegenbart, U; Salwender, H; Haas, R; Hahn, U; Schmier, JW; Ho, AD; Goldschmidt, H
      Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasone

      SUPPORTIVE CARE IN CANCER
    23. Verbeek, W; Ganser, A
      Evolving treatment options of myelodysplastic syndromes

      ANNALS OF HEMATOLOGY
    24. Bengala, C; Pazzagli, I; Innocenti, F; Donati, S; Favre, C; Menconi, MC; Greco, F; Danesi, R; Orlandini, C; Guarneri, V; Del Tacca, M; Conte, PF
      High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC)

      ANNALS OF ONCOLOGY
    25. Szelenyi, H; Kreuser, ED; Keilholz, U; Menssen, HD; Keitel-Wittig, C; Siehl, J; Knauf, W; Thiel, E
      Cyclophosphamide, adriamycin and dexamethasone (CAD) is a highly effectivetherapy for patients with advanced multiple myeloma

      ANNALS OF ONCOLOGY
    26. Gulbrandsen, N; Wisloff, F; Nord, E; Lenhoff, S; Hjorth, M; Westin, J
      Cost-utility analysis of high-dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myeloma

      EUROPEAN JOURNAL OF HAEMATOLOGY
    27. Biagi, E; Rovelli, A; De Lorenzo, P; Uderzo, C
      Autologous hematopoietic stem cell transplantation (AHSCT) as consolidation therapy for childhood acute myelogenous leukemia in 1st complete remission

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    28. Dominici, M; Campioni, D; Lanza, F; Luppi, M; Barozzi, P; Pauli, S; Milani, R; Cavazzini, F; Punturieri, M; Trovato, R; Torelli, G; Castoldi, G
      Angiogenesis in multiple myeloma: correlation between in vitro endothelialcolonies growth (CFU-En) and clinical-biological features

      LEUKEMIA
    29. Stephens, FO
      Induction chemotherapy: to downgrade aggressive cancers to improve curability by surgery and/or radiotherapy

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    30. Zaffaroni, N; Fiorentini, G; De Giorgi, U
      Hyperthermia and hypoxia: new developments in anticancer chemotherapy

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    31. Vrouenraets, BC; Eggermont, AMM; Hart, AAM; Klaase, JM; van Geel, AN; Nieweg, OE; Kroon, BBR
      Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor-alpha versus toxicity after melphalan alone

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    32. Dispenzieri, A; Lacy, MQ; Kyle, RA; Therneau, TM; Larson, DR; Rajkumar, SV; Fonseca, R; Greipp, PR; Witzig, TE; Lust, JA; Gertz, MA
      Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival

      JOURNAL OF CLINICAL ONCOLOGY
    33. Palumbo, A; Giaccone, L; Bertola, A; Pregno, P; Bringhen, S; Rus, C; Triolo, S; Gallo, E; Pileri, A; Boccadoro, M
      Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma

      HAEMATOLOGICA
    34. Genvresse, I; Wedding, U; Bokemeyer, C; Spath-Schwalbe, E
      Treatment of multiple myeloma in the elderly: Consensus of the cooperativegroup of geriatric oncology of the DGHO and DGG

      ONKOLOGIE
    35. Gharat, L; Taneja, R; Weerapreeyakul, N; Rege, B; Polli, J; Chikhale, PJ
      Targeted drug delivery systems 6. Intracellular bioreductive activation, uptake and transport of an anticancer drug delivery system across intestinalCaco-2 cell monolayers

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    36. Lecouvet, FE; Dechambre, S; Malghem, J; Ferrant, A; Vande Berg, BC; Maldague, B
      Bone marrow transplantation in patients with multiple myeloma: Prognostic significance of MR imaging

      AMERICAN JOURNAL OF ROENTGENOLOGY
    37. Papadopoulou, MV; Ji, M; Bloomer, WD
      Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in mice

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    38. Eroglu, A; Ozcan, H; Eryavuz, Y; Kocaoglu, H; Demirci, S; Aytac, SK
      Deep venous thrombosis of the extremity diagnosed by color Doppler ultrasonography after isolated limb perfusion

      TUMORI
    39. Sanchorawala, V; Wright, DG; Seldin, DC; Dember, LM; Finn, K; Falk, RH; Berk, J; Quillen, K; Skinner, M
      An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis

      BONE MARROW TRANSPLANTATION
    40. Devine, SM; Sanborn, R; Jessop, E; Stock, W; Huml, M; Peace, D; Wickrema, A; Yassine, M; Amin, K; Thomason, D; Chen, YH; Devine, H; Maningo, M; van Besien, K
      Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem celltransplant

      BONE MARROW TRANSPLANTATION
    41. Gutierrez-Delgado, F; Maloney, DG; Press, OW; Golden, J; Holmberg, LA; Maziarz, RT; Hooper, H; Buckner, CD; Appelbaum, FR; Bensinger, WI
      Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens

      BONE MARROW TRANSPLANTATION
    42. Kumar, S; Dispenzieri, A; Lacy, MQ; Litzow, MR; Gertz, MA
      High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis

      BONE MARROW TRANSPLANTATION
    43. Hogan, WJ; Lacy, MQ; Wiseman, GA; Fealey, RD; Dispenzieri, A; Gertz, MA
      Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation

      BONE MARROW TRANSPLANTATION
    44. Cesaro, S; Meloni, G; Messina, C; Pillon, M; Proglia, A; Lanino, E; Caniggia, M; Bagnulo, S; Pession, A; Locatelli, F
      High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation

      BONE MARROW TRANSPLANTATION
    45. Sirohi, B; Powles, R; Kulkarni, S; Rudin, C; Saso, R; Lal, R; Singhal, S; Mehta, J; Horton, C; Treleaven, J
      Comparison of new patients with Bence-Jones, IgG and IgA myeloma receivingsequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria

      BONE MARROW TRANSPLANTATION
    46. Sauerbrey, A; Bielack, S; Kempf-Bielack, B; Zoubek, A; Paulussen, M; Zintl, F
      High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma

      BONE MARROW TRANSPLANTATION
    47. Reynolds, C; Ratanatharathorn, V; Adams, P; Braun, T; Silver, S; Ayash, L; Carson, E; Eisbruch, A; Dawson, LA; McDonagh, K; Ferrara, J; Uberti, J
      Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma

      BONE MARROW TRANSPLANTATION
    48. Shimoni, A; Smith, TL; Aleman, A; Weber, D; Dimopoulos, M; Anderlini, P; Andersson, B; Claxton, D; Ueno, NT; Khouri, I; Donato, M; Korbling, M; Alexanian, R; Champlin, R; Giralt, S
      Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma

      BONE MARROW TRANSPLANTATION
    49. Vassal, G; Tranchand, B; Valteau-Couanet, D; Mahe, C; Couanet, D; Schoeppfer, C; Grill, J; Kalifa, C; Hill, C; Ardiet, C; Hartmann, O
      Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma

      BONE MARROW TRANSPLANTATION
    50. Bjorkstrand, B; Svensson, H; Goldschmidt, H; Ljungman, P; Apperley, J; Mandelli, F; Marcus, R; Boogaerts, M; Alegre, A; Remes, K; Cornelissen, JJ; Blade, J; Lenhoff, S; Iriondo, A; Carlson, K; Volin, L; Littlewood, T; Goldstone, AH; San Miguel, J; Schattenberg, A; Gahrton, G
      Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)

      BONE MARROW TRANSPLANTATION
    51. Reich, G; Held, T; Siegert, W; Kampf, D; Dorken, B; Maschmeyer, G
      Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation

      BONE MARROW TRANSPLANTATION
    52. Chen, CI; Abraham, R; Tsang, R; Crump, M; Keating, A; Stewart, AK
      Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes

      BONE MARROW TRANSPLANTATION
    53. Innet, LM; Haripershad, V; Van den Berg, J; Cooper, L
      Circuit and protocol for hypoxic hyperthermic isolated limb perfusion to treat malignant melanoma

      PERFUSION-UK
    54. Cattel, L; Buffa, E; De Simone, M; Cesana, P; Novello, S; Dosio, F; Ceruti, M
      Melphalan monitoring during hyperthermic perfusion of isolated limb for melanoma: Pharmacokinetic study and Tc-99m-albumin microcolloid technique

      ANTICANCER RESEARCH
    55. Matsuoka, T; Kaneda, Y; Li, TS; Tanaka, T; Zempo, N; Esato, K
      Increasing drug concentration in a rat lung tumor model by combining isolated lung perfusion with hypertensive chemotherapy

      ANTICANCER RESEARCH
    56. Moreau, P
      Treatment of AL amyloidosis

      REVUE DE MEDECINE INTERNE
    57. Chang, SS; Lu, CL; Tsay, SH; Chang, FY; Lee, SD
      Amyloidosis-induced gastrointestinal bleeding in a patient with multiple myeloma

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    58. Cwikiel, W; Bergqvist, L; Harnek, J
      Double-balloon catheter for isolated liver perfusion: An experimental study

      CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
    59. Vukovic, V; Nicklee, T; Hedley, DW
      Differential effects of buthionine sulphoximine in hypoxic and non-hypoxicregions of human cervical carcinoma xenografts

      RADIOTHERAPY AND ONCOLOGY
    60. Tominaga, R; Nakano, T; Shibata, S; Siraishi, K; Nagae, S; Nakayama, J; Yasui, H
      Systemic effects of hyperthermic isolated lower limb perfusion with carboplatin and interferon-beta

      ARTIFICIAL ORGANS
    61. Sipos, EP; Witham, TF; Ratan, R; Burger, PC; Baraban, J; Li, KW; Piantadosi, S; Brem, H
      L-buthionine sulfoximine potentiates the antitumor effect of 4-hydroperoxycyclophosphamide when administered locally in a rat glioma model

      NEUROSURGERY
    62. Kazmi, MA; Ahsan, G; Schey, SA
      The effects of prior induction therapy with melphalan on subsequent peripheral blood progenitor cell transplantation for myeloma

      CLINICAL AND LABORATORY HAEMATOLOGY
    63. Bartlett, DL; Libutti, SK; Figg, WD; Fraker, DL; Alexander, HR
      Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer

      SURGERY
    64. Barlogie, B
      Introduction to therapies in multiple myeloma

      SEMINARS IN HEMATOLOGY
    65. Sirohi, B; Kulkarni, S; Powles, R
      Some early phase II trials in previously untreated multiple myeloma: The Royal Marsden experience

      SEMINARS IN HEMATOLOGY
    66. Bjorkstrand, B
      European group for blood and marrow transplantation registry studies in multiple myeloma

      SEMINARS IN HEMATOLOGY
    67. Barlogie, B; Zangari, M; Spencer, T; Fassas, A; Anaissie, E; Badros, A; Cromer, J; Tricot, G
      Thalidomide in the management of multiple myeloma

      SEMINARS IN HEMATOLOGY
    68. Khan, MF; Falk, RH
      Amyloidosis

      POSTGRADUATE MEDICAL JOURNAL
    69. Kalra, S; Utz, JP; Edell, ES; Foote, RL
      External-beam radiation therapy in the treatment of diffuse tracheobronchial amyloidosis

      MAYO CLINIC PROCEEDINGS
    70. Finley, JW; Hanypsiak, B; McGrath, B; Kraybill, W; Gibbs, JF
      Clear cell sarcoma: The Roswell Park experience

      JOURNAL OF SURGICAL ONCOLOGY
    71. Muldoon, LL; Walker-Rosenfeld, SL; Hale, C; Purcell, SE; Bennett, LC; Neuwelt, EA
      Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    72. Killian, DM; Chikhale, PJ
      A bioreversible prodrug approach designed to shift mechanism of brain uptake for amino-acid-containing anticancer agents

      JOURNAL OF NEUROCHEMISTRY
    73. Shtrasburg, S; Pras, M; Gal, R; Salai, M; Livneh, A
      Inhibition of the second phase of amyloidogenesis in a mouse model by a single-dose colchicine regimen

      JOURNAL OF LABORATORY AND CLINICAL MEDICINE
    74. Leroux, E; Auzenne, E; Weidner, D; Wu, ZY; Donato, NJ; Klostergaard, J
      Febrile and acute hyperthermia enhance TNF-induced necrosis of murine L929fibrosarcoma cells via caspase-regulated production of reactive oxygen intermediates

      JOURNAL OF CELLULAR PHYSIOLOGY
    75. Ghanem, G; Loir, B; Morandini, R; Sales, F; Lienard, D; Eggermont, A; Lejeune, F
      On the release and half-life of S100B protein in the peripheral blood of melanoma patients

      INTERNATIONAL JOURNAL OF CANCER
    76. Liao, RL; Jain, M; Teller, P; Connors, LH; Ngoy, S; Skinner, M; Falk, RH; Apstein, CS
      Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts

      CIRCULATION
    77. Neuwelt, EA; Pagel, MA; Hasler, BP; Deloughery, TG; Muldoon, LL
      Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administrationof alkylators, with or without glutathione depletion in a rat model

      CANCER RESEARCH
    78. Badros, A; Barlogie, B; Siegel, E; Roberts, J; Langmaid, C; Zangari, M; Desikan, R; Shaver, MJ; Fassas, A; McConnell, S; Muwalla, F; Barri, Y; Anaissie, E; Munshi, N; Tricot, G
      Results of autologous stem cell transplant in multiple myeloma patients with renal failure

      BRITISH JOURNAL OF HAEMATOLOGY
    79. Casassus, P; Gibson, J; Joshua, DE; Matthews, J; Diaz, JC; Gertz, MA; Kyle, R; Leong, T; Oken, MM; Fritz, E; Ludwig, H; Corrado, C; Lastiri, F; Peest, D; Grosbois, B; Vela-Ojeda, J; Avvisati, G; Mandelli, F; Petrucci, MT; Capnist, G; Child, JA; Drayson, MT; Dunn, J; MacLennan, I; Mellstedt, H; Osterborg, A; Rodjer, S; Turesson, I; Westin, J; Bergsagel, D; Browman, GP; Shustik, C; Zee, B; Hjorth, M; Holmberg, E; Rodjer, S; Turesson, I; Westin, J; Alison, R; Clarke, M; Elphinstone, P; Evans, V; Gray, R; Hicks, C; James, S; MacKinnon, L; Peto, R; Richards, S; Wheatley, K; Blade, J; Fontanillas, M; San Miguel, J; Aitchison, R; Newland, AC; Cunningham, D; Malpas, J; Powles, RL; Montuoro, A; Jacobson, J; Salmon, S
      Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients

      BRITISH JOURNAL OF HAEMATOLOGY
    80. McCloskey, EV; Dunn, JA; Kanis, JA; MacLennan, ICM; Drayson, MT
      Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma

      BRITISH JOURNAL OF HAEMATOLOGY
    81. Desikan, KR; Tricot, G; Munshi, NC; Anaissie, E; Spoon, D; Fassas, A; Toor, A; Zangari, M; Badros, A; Morris, C; Vesole, DH; Siegel, D; Jagannath, S; Barlogie, B
      Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone

      BRITISH JOURNAL OF HAEMATOLOGY
    82. Thompson, JF; Siebert, GA; Anissimov, YG; Smithers, BM; Doubrovsky, A; Anderson, CD; Roberts, MS
      Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies

      BRITISH JOURNAL OF CANCER
    83. Comenzo, RL; Zhang, Y; Martinez, C; Osman, K; Herrera, GA
      The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V-L germ line gene use and clonal plasma cell burden

      BLOOD
    84. Choufani, EB; Sanchorawala, V; Ernst, T; Quillen, K; Skinner, M; Wright, DG; Seldin, DC
      Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy

      BLOOD
    85. Woods, WG; Neudorf, S; Gold, S; Sanders, J; Buckley, JD; Barnard, DR; Dusenbery, K; DeSwarte, J; Arthur, DC; Lange, BJ; Kobrinsky, NL
      A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group

      BLOOD
    86. Yanagida, O; Kanai, Y; Chairoungdua, A; Kim, DK; Segawa, H; Nii, T; Cha, SH; Matsuo, H; Fukushima, J; Fukasawa, Y; Tani, Y; Taketani, Y; Uchino, H; Kim, JY; Inatomi, J; Okayasu, I; Miyamoto, K; Takeda, E; Goya, T; Endou, H
      Human L-type amino acid transporter 1 (LAT1): characterization of functionand expression in tumor cell lines

      BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
    87. van Ijken, MGA; van Etten, B; de Wilt, JHW; van Tiel, ST; ten Hagen, TLM; Eggermont, AMM
      Tumor necrosis factor-alpha augments tumor effects in isolated hepatic perfusion with melphalan in a rat sarcoma model

      JOURNAL OF IMMUNOTHERAPY
    88. Eggermont, AMM
      TNF registered in Europe: Does TNF get a second chance?

      JOURNAL OF IMMUNOTHERAPY
    89. Iggo, N; Littlewood, T; Winearls, CG
      Prospects for effective treatment of AL amyloidosis?

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    90. Hoes, I; Van Dongen, W; Lemiere, F; Esmans, EL; Van Bockstaele, D; Berneman, ZN
      Comparison between capillary and nano liquid chromatography-electrospray mass spectrometry for the analysis of minor DNA-melphalan adducts

      JOURNAL OF CHROMATOGRAPHY B
    91. Ferguson, LR; Turner, PM; Denny, WA
      The mutagenic spectrum of acridine-linked aniline nitrogen mustards in AS52 cells: implications of DNA targeting with high selectivity for adenine orguanine bases

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    92. Ruegg, C; Dormond, O; Oguey, D; Lejeune, FJ
      Tumor necrosis factor: clinical use and mechanisms of action

      DRUG RESISTANCE UPDATES
    93. Blade, J; Esteve, J
      Viewpoint on the impact of interferon in the treatment of multiple myeloma: benefit for a small proportion of patients?

      MEDICAL ONCOLOGY
    94. Sezer, O; Niemoller, K; Jakob, C; Langelotz, C; Eucker, J; Possinger, K
      Novel approaches to the treatment of primary amyloidosis

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    95. Raje, N; Kica, G; Chauhan, D; Zhang, YN; Teoh, G; Treon, SP; Hideshima, T; Deng, JH; Gao, SJ; Alsina, M; Wally, J; Davies, FE; Tai, YT; Pinkus, GS; Pinkus, JL; Skinner, M; Comenzo, RL; Anderson, KC
      Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosis

      AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION
    96. Skinner, M
      AL amyloidosis: the last 30 years

      AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION
    97. Ronco, P; Aucouturier, P; Mougenot, B
      Plasma cell dyscrasia-related glomerulopathies and Fanconi's syndrome: a molecular approach

      JOURNAL OF NEPHROLOGY
    98. Curnis, F; Sacchi, A; Borgna, L; Magni, F; Gasparri, A; Corti, A
      Enhancement of tumor necrosis factor a antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)

      NATURE BIOTECHNOLOGY
    99. Schenkein, DP; Koc, Y; Alcindor, T; Stadtmauer, EA; Miller, KB; Cooper, BW; Partridge, AH; Lazarus, HM
      Treatment of primary resistant or relapsed multiple myeloma with high-dosechemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    100. Pendyala, L; Creaven, PJ; Schwartz, G; Meropol, NJ; Bolanowska-Higdon, W; Zdanowicz, J; Murphy, M; Perez, R
      Intravenous ifosfamide/mesna is associated with depletion of plasma thiolswithout depletion of leukocyte glutathione

      CLINICAL CANCER RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 17:49:15